2

Bookmark and Share New leukemia treatment shows promise

hollowman's site:
www.tubecancer.com

A Phosphoinositide 3-kinase inhibitor (PI3K inhibitor) is a potential medical drug that functions by inhibiting a Phosphoinositide 3-kinase enzyme which is part of the PI3K/AKT/mTOR pathway, which plays a key role in cancer. Inhibiting this pathway often suppresses tumor growth. There are a number of different classes and isoforms of PI3Ks. Class 1 PI3Ks have a catalytic subunit known as p110, with four types (isoforms) - p110 alpha, p110 beta, p110 gamma and p110 delta. The inhibitors being studied inhibit one or more isoforms of the class I PI3Ks.

 Read » New leukemia treatment shows promise
hollowman's picture
Published 41 weeks 14 hours ago
Category: Health | Tags: | Referrer: Kyriana

Recent comments

Web Hosting Free Trial

Dreamhost
$50 OFF ANY PLAN WITH
PROMO CODE: SheToldMe


Or a limited offer, $100 off a 2-year plan!